Viewing Study NCT03108833


Ignite Creation Date: 2025-12-25 @ 2:47 AM
Ignite Modification Date: 2026-04-23 @ 8:24 PM
Study NCT ID: NCT03108833
Status: COMPLETED
Last Update Posted: 2021-03-18
First Post: 2017-04-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Trial in Recombinant Human Prourokinase to Treat Acute Pulmonary Embolism
Sponsor: Tasly Biopharmaceuticals Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module